Featured Clinical Trials
The UNC Brain Metastasis Specialty Clinic seeks to offer a portfolio of clinical trials. Some of our most exciting trials are featured below.
N107C: A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease.
PI: Timothy Zagar, MD
Contact: Becky Lynch. Telephone (919) 843-7112. Email.
RTOG0933: A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases
PI: Timothy Zagar, MD
Contact: Lori Stravers. Telephone: (919) 445-5242 or toll free 1-877-668-0683. Email.
LCCC1025: A Phase II Study Evaluating The Efficacy And Tolerability Of Everolimus (RAD001) In Combination With Trastuzumab And Vinorelbine In The Treatment Of Progressive HER2-Positive Breast Cancer Brain Metastases
PI: Carey Anders, MD
Contact: Donna Rowe, RN. Telephone (919) 966-7359 or toll free 1-877-668-0683. Email.
GRN 1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
PI: Carey Anders, MD
Contact: Rachel Phipps. Telephone (919) 966-4432 or toll free 1-877-668-0683. Email
DFCI 10-107 Prospective Study of Neurocognitive Outcomes following Whole Brain Radiotherapy for Newly Diagnosed Brain Metastasis in Breast Cancer Patients.
PI: Carey Anders, MD
Contact: Sonali Rege. Telephone (919) 966-4432 or toll free 1-877-668-0683. Email.
